First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology

BACKGROUND The risk of pre-eclampsia (PE) increases in twin pregnancies, especially when assisted reproduction technologies (ART) are used. The aim of this study was to assess angiogenic/anti-angiogenic factors in maternal serum in the first trimester of twin pregnancies and establish if the mode of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human reproduction (Oxford) 2012-02, Vol.27 (2), p.358-365
Hauptverfasser: Sánchez, O, Llurba, E., Marsal, G., Domínguez, C., Aulesa, C., Sánchez-Durán, M.A., Goya, M.M., Alijotas-Reig, J., Carreras, E., Cabero, L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 365
container_issue 2
container_start_page 358
container_title Human reproduction (Oxford)
container_volume 27
creator Sánchez, O
Llurba, E.
Marsal, G.
Domínguez, C.
Aulesa, C.
Sánchez-Durán, M.A.
Goya, M.M.
Alijotas-Reig, J.
Carreras, E.
Cabero, L.
description BACKGROUND The risk of pre-eclampsia (PE) increases in twin pregnancies, especially when assisted reproduction technologies (ART) are used. The aim of this study was to assess angiogenic/anti-angiogenic factors in maternal serum in the first trimester of twin pregnancies and establish if the mode of conception influences angiogenic status. METHODS This prospective study enrolled women with twin (n = 61) and singleton (n = 50) pregnancies. Dichorionic twin pregnancies were divided into two groups according to their mode of conception. Singleton pregnancies were used as the control group. Soluble fms-like tyrosine kinase (sFlt-1), free placental growth factor (PlGF) and soluble endoglin (sEng) concentrations were measured in the first trimester maternal serum. RESULTS In the first trimester, women with twin pregnancies had higher serum concentrations of the anti-angiogenic factor sFlt-1 than that with singleton pregnancies (3924 ± 250 versus 2426 ± 162 pg/ml, respectively; P < 0.001). Maternal serum PlGF concentrations were lower in singleton pregnancies than those in twin pregnancies (37 ± 3.7 versus 59 ± 5.6, respectively; P < 0.001). Serum concentrations of sFlt-1 were higher in twin pregnancies conceived by ART than those in spontaneous twin pregnancies (4313 ± 389 versus 3522 ± 300 pg/ml, respectively; P < 0.05). No differences between groups were observed for sEng. CONCLUSIONS In the first trimester, twin pregnancies conceived using ART showed a heightened anti-angiogenic status that could explain the increased risk of PE in these cases.
doi_str_mv 10.1093/humrep/der394
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_916519235</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/humrep/der394</oup_id><sourcerecordid>916519235</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-4bda71939db5eca4bc5eb2a7c4bfe47289752fcc8954e1bb7459d135a05a923c3</originalsourceid><addsrcrecordid>eNqFkMtP3DAQh62qqCzQY6-VL1W5hPUzWXNDiEclJC5wjhxnsusqcYLHEeLUf71eZVuOXPyaT7_xfIR84-yCMyPXu3mIMK1biNKoT2TFVckKITX7TFZMlJuC85IfkxPE34zl46b8Qo6FyK9GmRX5c-sjJpqiHwATRIoQ54HasPXjFoJ3axuSL97vFJNNM1IfaHrNyxRhG2xwHvCSRuht8mPAnZ_oq087ahF9zm1zaYpjO7t9mSZwuzD24_btjBx1tkf4ethPyfPtzdP1ffHwePfr-uqhcHmsVKimtRU30rSNBmdV4zQ0wlZONR2oSmxMpUXn3MZoBbxpKqVNy6W2TFsjpJOn5OeSm3_xMudR68Gjg763AcYZa8NLzTOpM1kspIsjYoSunrIcG99qzuq98npRXi_KM__9kDw3A7T_6X-OM_DjAFh0tu_i3ha-c1orWQmZufOFG-fpg55_Ab68njU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>916519235</pqid></control><display><type>article</type><title>First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Sánchez, O ; Llurba, E. ; Marsal, G. ; Domínguez, C. ; Aulesa, C. ; Sánchez-Durán, M.A. ; Goya, M.M. ; Alijotas-Reig, J. ; Carreras, E. ; Cabero, L.</creator><creatorcontrib>Sánchez, O ; Llurba, E. ; Marsal, G. ; Domínguez, C. ; Aulesa, C. ; Sánchez-Durán, M.A. ; Goya, M.M. ; Alijotas-Reig, J. ; Carreras, E. ; Cabero, L.</creatorcontrib><description>BACKGROUND The risk of pre-eclampsia (PE) increases in twin pregnancies, especially when assisted reproduction technologies (ART) are used. The aim of this study was to assess angiogenic/anti-angiogenic factors in maternal serum in the first trimester of twin pregnancies and establish if the mode of conception influences angiogenic status. METHODS This prospective study enrolled women with twin (n = 61) and singleton (n = 50) pregnancies. Dichorionic twin pregnancies were divided into two groups according to their mode of conception. Singleton pregnancies were used as the control group. Soluble fms-like tyrosine kinase (sFlt-1), free placental growth factor (PlGF) and soluble endoglin (sEng) concentrations were measured in the first trimester maternal serum. RESULTS In the first trimester, women with twin pregnancies had higher serum concentrations of the anti-angiogenic factor sFlt-1 than that with singleton pregnancies (3924 ± 250 versus 2426 ± 162 pg/ml, respectively; P &lt; 0.001). Maternal serum PlGF concentrations were lower in singleton pregnancies than those in twin pregnancies (37 ± 3.7 versus 59 ± 5.6, respectively; P &lt; 0.001). Serum concentrations of sFlt-1 were higher in twin pregnancies conceived by ART than those in spontaneous twin pregnancies (4313 ± 389 versus 3522 ± 300 pg/ml, respectively; P &lt; 0.05). No differences between groups were observed for sEng. CONCLUSIONS In the first trimester, twin pregnancies conceived using ART showed a heightened anti-angiogenic status that could explain the increased risk of PE in these cases.</description><identifier>ISSN: 0268-1161</identifier><identifier>EISSN: 1460-2350</identifier><identifier>DOI: 10.1093/humrep/der394</identifier><identifier>PMID: 22116949</identifier><identifier>CODEN: HUREEE</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Angiogenesis Inhibitors - blood ; Angiogenic Proteins - blood ; Antigens, CD - blood ; Antigens, CD - chemistry ; Biological and medical sciences ; Cohort Studies ; Endoglin ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; Placenta Growth Factor ; Pre-Eclampsia - epidemiology ; Pre-Eclampsia - etiology ; Pregnancy ; Pregnancy Proteins - blood ; Pregnancy Proteins - chemistry ; Pregnancy Trimester, First ; Pregnancy, Twin - blood ; Prospective Studies ; Receptors, Cell Surface - blood ; Receptors, Cell Surface - chemistry ; Reproductive Techniques, Assisted - adverse effects ; Risk ; Solubility ; Spain - epidemiology ; Vascular Endothelial Growth Factor Receptor-1 - blood ; Vascular Endothelial Growth Factor Receptor-1 - chemistry</subject><ispartof>Human reproduction (Oxford), 2012-02, Vol.27 (2), p.358-365</ispartof><rights>The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2011</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-4bda71939db5eca4bc5eb2a7c4bfe47289752fcc8954e1bb7459d135a05a923c3</citedby><cites>FETCH-LOGICAL-c394t-4bda71939db5eca4bc5eb2a7c4bfe47289752fcc8954e1bb7459d135a05a923c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25543723$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22116949$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sánchez, O</creatorcontrib><creatorcontrib>Llurba, E.</creatorcontrib><creatorcontrib>Marsal, G.</creatorcontrib><creatorcontrib>Domínguez, C.</creatorcontrib><creatorcontrib>Aulesa, C.</creatorcontrib><creatorcontrib>Sánchez-Durán, M.A.</creatorcontrib><creatorcontrib>Goya, M.M.</creatorcontrib><creatorcontrib>Alijotas-Reig, J.</creatorcontrib><creatorcontrib>Carreras, E.</creatorcontrib><creatorcontrib>Cabero, L.</creatorcontrib><title>First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology</title><title>Human reproduction (Oxford)</title><addtitle>Hum Reprod</addtitle><description>BACKGROUND The risk of pre-eclampsia (PE) increases in twin pregnancies, especially when assisted reproduction technologies (ART) are used. The aim of this study was to assess angiogenic/anti-angiogenic factors in maternal serum in the first trimester of twin pregnancies and establish if the mode of conception influences angiogenic status. METHODS This prospective study enrolled women with twin (n = 61) and singleton (n = 50) pregnancies. Dichorionic twin pregnancies were divided into two groups according to their mode of conception. Singleton pregnancies were used as the control group. Soluble fms-like tyrosine kinase (sFlt-1), free placental growth factor (PlGF) and soluble endoglin (sEng) concentrations were measured in the first trimester maternal serum. RESULTS In the first trimester, women with twin pregnancies had higher serum concentrations of the anti-angiogenic factor sFlt-1 than that with singleton pregnancies (3924 ± 250 versus 2426 ± 162 pg/ml, respectively; P &lt; 0.001). Maternal serum PlGF concentrations were lower in singleton pregnancies than those in twin pregnancies (37 ± 3.7 versus 59 ± 5.6, respectively; P &lt; 0.001). Serum concentrations of sFlt-1 were higher in twin pregnancies conceived by ART than those in spontaneous twin pregnancies (4313 ± 389 versus 3522 ± 300 pg/ml, respectively; P &lt; 0.05). No differences between groups were observed for sEng. CONCLUSIONS In the first trimester, twin pregnancies conceived using ART showed a heightened anti-angiogenic status that could explain the increased risk of PE in these cases.</description><subject>Adult</subject><subject>Angiogenesis Inhibitors - blood</subject><subject>Angiogenic Proteins - blood</subject><subject>Antigens, CD - blood</subject><subject>Antigens, CD - chemistry</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>Endoglin</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Placenta Growth Factor</subject><subject>Pre-Eclampsia - epidemiology</subject><subject>Pre-Eclampsia - etiology</subject><subject>Pregnancy</subject><subject>Pregnancy Proteins - blood</subject><subject>Pregnancy Proteins - chemistry</subject><subject>Pregnancy Trimester, First</subject><subject>Pregnancy, Twin - blood</subject><subject>Prospective Studies</subject><subject>Receptors, Cell Surface - blood</subject><subject>Receptors, Cell Surface - chemistry</subject><subject>Reproductive Techniques, Assisted - adverse effects</subject><subject>Risk</subject><subject>Solubility</subject><subject>Spain - epidemiology</subject><subject>Vascular Endothelial Growth Factor Receptor-1 - blood</subject><subject>Vascular Endothelial Growth Factor Receptor-1 - chemistry</subject><issn>0268-1161</issn><issn>1460-2350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtP3DAQh62qqCzQY6-VL1W5hPUzWXNDiEclJC5wjhxnsusqcYLHEeLUf71eZVuOXPyaT7_xfIR84-yCMyPXu3mIMK1biNKoT2TFVckKITX7TFZMlJuC85IfkxPE34zl46b8Qo6FyK9GmRX5c-sjJpqiHwATRIoQ54HasPXjFoJ3axuSL97vFJNNM1IfaHrNyxRhG2xwHvCSRuht8mPAnZ_oq087ahF9zm1zaYpjO7t9mSZwuzD24_btjBx1tkf4ethPyfPtzdP1ffHwePfr-uqhcHmsVKimtRU30rSNBmdV4zQ0wlZONR2oSmxMpUXn3MZoBbxpKqVNy6W2TFsjpJOn5OeSm3_xMudR68Gjg763AcYZa8NLzTOpM1kspIsjYoSunrIcG99qzuq98npRXi_KM__9kDw3A7T_6X-OM_DjAFh0tu_i3ha-c1orWQmZufOFG-fpg55_Ab68njU</recordid><startdate>20120201</startdate><enddate>20120201</enddate><creator>Sánchez, O</creator><creator>Llurba, E.</creator><creator>Marsal, G.</creator><creator>Domínguez, C.</creator><creator>Aulesa, C.</creator><creator>Sánchez-Durán, M.A.</creator><creator>Goya, M.M.</creator><creator>Alijotas-Reig, J.</creator><creator>Carreras, E.</creator><creator>Cabero, L.</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120201</creationdate><title>First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology</title><author>Sánchez, O ; Llurba, E. ; Marsal, G. ; Domínguez, C. ; Aulesa, C. ; Sánchez-Durán, M.A. ; Goya, M.M. ; Alijotas-Reig, J. ; Carreras, E. ; Cabero, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-4bda71939db5eca4bc5eb2a7c4bfe47289752fcc8954e1bb7459d135a05a923c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Angiogenesis Inhibitors - blood</topic><topic>Angiogenic Proteins - blood</topic><topic>Antigens, CD - blood</topic><topic>Antigens, CD - chemistry</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>Endoglin</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Placenta Growth Factor</topic><topic>Pre-Eclampsia - epidemiology</topic><topic>Pre-Eclampsia - etiology</topic><topic>Pregnancy</topic><topic>Pregnancy Proteins - blood</topic><topic>Pregnancy Proteins - chemistry</topic><topic>Pregnancy Trimester, First</topic><topic>Pregnancy, Twin - blood</topic><topic>Prospective Studies</topic><topic>Receptors, Cell Surface - blood</topic><topic>Receptors, Cell Surface - chemistry</topic><topic>Reproductive Techniques, Assisted - adverse effects</topic><topic>Risk</topic><topic>Solubility</topic><topic>Spain - epidemiology</topic><topic>Vascular Endothelial Growth Factor Receptor-1 - blood</topic><topic>Vascular Endothelial Growth Factor Receptor-1 - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez, O</creatorcontrib><creatorcontrib>Llurba, E.</creatorcontrib><creatorcontrib>Marsal, G.</creatorcontrib><creatorcontrib>Domínguez, C.</creatorcontrib><creatorcontrib>Aulesa, C.</creatorcontrib><creatorcontrib>Sánchez-Durán, M.A.</creatorcontrib><creatorcontrib>Goya, M.M.</creatorcontrib><creatorcontrib>Alijotas-Reig, J.</creatorcontrib><creatorcontrib>Carreras, E.</creatorcontrib><creatorcontrib>Cabero, L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez, O</au><au>Llurba, E.</au><au>Marsal, G.</au><au>Domínguez, C.</au><au>Aulesa, C.</au><au>Sánchez-Durán, M.A.</au><au>Goya, M.M.</au><au>Alijotas-Reig, J.</au><au>Carreras, E.</au><au>Cabero, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology</atitle><jtitle>Human reproduction (Oxford)</jtitle><addtitle>Hum Reprod</addtitle><date>2012-02-01</date><risdate>2012</risdate><volume>27</volume><issue>2</issue><spage>358</spage><epage>365</epage><pages>358-365</pages><issn>0268-1161</issn><eissn>1460-2350</eissn><coden>HUREEE</coden><abstract>BACKGROUND The risk of pre-eclampsia (PE) increases in twin pregnancies, especially when assisted reproduction technologies (ART) are used. The aim of this study was to assess angiogenic/anti-angiogenic factors in maternal serum in the first trimester of twin pregnancies and establish if the mode of conception influences angiogenic status. METHODS This prospective study enrolled women with twin (n = 61) and singleton (n = 50) pregnancies. Dichorionic twin pregnancies were divided into two groups according to their mode of conception. Singleton pregnancies were used as the control group. Soluble fms-like tyrosine kinase (sFlt-1), free placental growth factor (PlGF) and soluble endoglin (sEng) concentrations were measured in the first trimester maternal serum. RESULTS In the first trimester, women with twin pregnancies had higher serum concentrations of the anti-angiogenic factor sFlt-1 than that with singleton pregnancies (3924 ± 250 versus 2426 ± 162 pg/ml, respectively; P &lt; 0.001). Maternal serum PlGF concentrations were lower in singleton pregnancies than those in twin pregnancies (37 ± 3.7 versus 59 ± 5.6, respectively; P &lt; 0.001). Serum concentrations of sFlt-1 were higher in twin pregnancies conceived by ART than those in spontaneous twin pregnancies (4313 ± 389 versus 3522 ± 300 pg/ml, respectively; P &lt; 0.05). No differences between groups were observed for sEng. CONCLUSIONS In the first trimester, twin pregnancies conceived using ART showed a heightened anti-angiogenic status that could explain the increased risk of PE in these cases.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>22116949</pmid><doi>10.1093/humrep/der394</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-1161
ispartof Human reproduction (Oxford), 2012-02, Vol.27 (2), p.358-365
issn 0268-1161
1460-2350
language eng
recordid cdi_proquest_miscellaneous_916519235
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adult
Angiogenesis Inhibitors - blood
Angiogenic Proteins - blood
Antigens, CD - blood
Antigens, CD - chemistry
Biological and medical sciences
Cohort Studies
Endoglin
Female
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
Placenta Growth Factor
Pre-Eclampsia - epidemiology
Pre-Eclampsia - etiology
Pregnancy
Pregnancy Proteins - blood
Pregnancy Proteins - chemistry
Pregnancy Trimester, First
Pregnancy, Twin - blood
Prospective Studies
Receptors, Cell Surface - blood
Receptors, Cell Surface - chemistry
Reproductive Techniques, Assisted - adverse effects
Risk
Solubility
Spain - epidemiology
Vascular Endothelial Growth Factor Receptor-1 - blood
Vascular Endothelial Growth Factor Receptor-1 - chemistry
title First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A45%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20trimester%20serum%20angiogenic/anti-angiogenic%20status%20in%20twin%20pregnancies:%20relationship%20with%20assisted%20reproduction%20technology&rft.jtitle=Human%20reproduction%20(Oxford)&rft.au=S%C3%A1nchez,%20O&rft.date=2012-02-01&rft.volume=27&rft.issue=2&rft.spage=358&rft.epage=365&rft.pages=358-365&rft.issn=0268-1161&rft.eissn=1460-2350&rft.coden=HUREEE&rft_id=info:doi/10.1093/humrep/der394&rft_dat=%3Cproquest_cross%3E916519235%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=916519235&rft_id=info:pmid/22116949&rft_oup_id=10.1093/humrep/der394&rfr_iscdi=true